NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Trial of IDH305 in IDH1 Mutant Grade II or III Glioma

Phase 2

Withdrawn

Conditions: Glioma

Interventions: Drug: IDH305

First Posted Date: 2016-11-30

Last Posted Date: 2017-12-20

Lead Sponsor: NYU Langone Health

Registration Number: NCT02977689

Locations: 🇺🇸
Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center, New York, New York, United States

A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 1

Completed

Conditions: Addiction

Interventions: Behavioral: Interviews with Stakeholders

First Posted Date: 2016-11-28

Last Posted Date: 2022-08-29

Lead Sponsor: NYU Langone Health

Target Recruit Count: 67

Registration Number: NCT02974335

Locations: 🇺🇸
Massachusettes General Hospital, Boston, Massachusetts, United States
🇺🇸
Oregon Health and Science University, Portland, Oregon, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Improving Behavioral Health Care for Children With ADHD

Not Applicable

Completed

Conditions: ADHD

Interventions: Behavioral: Behavioral Parent Training (BPT)

First Posted Date: 2016-11-23

Last Posted Date: 2017-09-11

Lead Sponsor: NYU Langone Health

Target Recruit Count: 7

Registration Number: NCT02972086

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma

Phase 2

Completed

Conditions: Melanoma

Interventions: Biological: Nivolumab
Biological: Ipilimumab

First Posted Date: 2016-11-22

Last Posted Date: 2024-04-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 18

Registration Number: NCT02970981

Locations: 🇺🇸
Laura and Isaac Perlmutter Cancer Center, New York, New York, United States

A New Paradigm for Vitamin D Sufficiency

Not Applicable

Completed

Conditions: New Biomarkers for Measuring Vitamin D Level

Interventions: Other: Placebo
Dietary Supplement: Vitamin D Supplementation
Dietary Supplement: Calcium

First Posted Date: 2016-11-21

Last Posted Date: 2021-10-22

Lead Sponsor: NYU Langone Health

Target Recruit Count: 444

Registration Number: NCT02969850

Locations: 🇺🇸
Winthrop University Hospital, Mineola, New York, United States

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

Phase 2

Completed

Conditions: Glioblastoma

Interventions: Biological: Avelumab
Radiation: Hypofractionated radiation therapy (HFRT)

First Posted Date: 2016-11-21

Last Posted Date: 2022-06-29

Lead Sponsor: NYU Langone Health

Target Recruit Count: 6

Registration Number: NCT02968940

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center, New York, New York, United States
🇺🇸
UCSF Medical Center, San Francisco, California, United States

and more 1 locations

A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 3

Completed

Conditions: Substance Abuse

Interventions: Behavioral: Meetings with implementation leader(s)
Behavioral: the SAAS survey
Behavioral: Patient surveys

First Posted Date: 2016-11-15

Last Posted Date: 2022-08-29

Lead Sponsor: NYU Langone Health

Target Recruit Count: 113123

Registration Number: NCT02963948

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

The Effect of Distractive Auditory Stimuli (Music) on Dyspnea and Anxiety During Exercise in Adults With Chronic Respiratory Diseases

Not Applicable

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Procedure: Distractive Auditory Stimuli
Procedure: No Distractive Auditory Stimuli

First Posted Date: 2016-11-04

Last Posted Date: 2021-08-03

Lead Sponsor: NYU Langone Health

Target Recruit Count: 8

Registration Number: NCT02955108

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Usability and Pilot Testing - Intervention for Smoking Cessation

Not Applicable

Withdrawn

Conditions: Smoking
Smoking Cessation

Interventions: Device: Quit Smoking Phone Application

First Posted Date: 2016-11-04

Last Posted Date: 2018-10-09

Lead Sponsor: NYU Langone Health

Registration Number: NCT02955095

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department

Phase 4

Withdrawn

Conditions: Migraine

Interventions: Drug: Preventative Medication (PM)
Behavioral: Enhanced Usual Care
Behavioral: PMR (progressive muscle relaxation therapy)

First Posted Date: 2016-10-26

Last Posted Date: 2019-11-29

Lead Sponsor: NYU Langone Health

Registration Number: NCT02945839

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy